Detalhe da pesquisa
1.
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms.
Immunity
; 42(5): 815-25, 2015 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25992858
2.
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy.
J Immunol
; 201(7): 2094-2106, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30104245
3.
Virtual Photon Approximation for Three-Body Interatomic Coulombic Decay.
Phys Rev Lett
; 122(15): 153401, 2019 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31050514
4.
Interatomic Coulombic Decay Mediated by Ultrafast Superexchange Energy Transfer.
Phys Rev Lett
; 119(8): 083403, 2017 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28952742
5.
Novel IL-2-Poly(HPMA)Nanoconjugate Based Immunotherapy.
J Biomed Nanotechnol
; 11(9): 1662-73, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26485935
6.
Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera.
Immunol Lett
; 159(1-2): 1-10, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24512738
7.
Chimera of IL-2 linked to light chain of anti-IL-2 mAb mimics IL-2/anti-IL-2 mAb complexes both structurally and functionally.
ACS Chem Biol
; 8(5): 871-6, 2013 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23419043